TrialX Updates: Presenting Innovations in Space Health Research & Remote Data Collection at the NASA HRP IWS 2025; an AI Powered Clinical Trial Finder; SCOPE 2025 & more…
Kicking off 2025 on an exciting note, our team was thrilled to participate in the NASA Human Research Program’s 2025 Investigators’ Workshop (IWS), where our Co-founder & CEO, Sharib Khan, presented the groundbreaking EXPAND Database & Biorepository – developed in collaboration with the Translational Research Institute for Space Health (TRISH) – to collect research, flight, and clinical data from commercial spaceflight missions. Dr. Chintan Patel, our CTO & Co-founder, along with lead engineer Syed Gufran, showcased the HERMES platform, an innovative system for securely collecting and transferring health data during space missions. And that’s not all—there was a fun element too! Learn more.
What’s New at TrialX! 🚀
PRODUCT UPDATES
🔍 AN AI-POWERED GLOBAL CLINICAL TRIAL FINDER
We’re excited to collaborate with Let’s Win Pancreatic Cancer and power their cutting-edge global Clinical Trial Finder. This AI-driven tool simplifies access to essential clinical trial information by delivering personalized results tailored to a user’s location and health history. With advanced AI-guided searches and bilingual support available in English and Spanish, the Trial Finder aims to make clinical trial participation more inclusive and accessible for the worldwide pancreatic cancer community. Let’s Win Pancreatic Cancer remains a trusted ally for patients and caregivers, providing invaluable resources and support throughout their journey. Learn more. Read More.
🤳 REMOTE DATA COLLECTION FOR A LEADING CLINICAL RESEARCH STUDY
Leveraging TrialX’s remote data collection solutions researchers at the University of Iowa have developed the SAYSTOP study app to explore a critical question: Is it safe for patients with urinary tract infections to stop antibiotics when they feel better, rather than completing the full course? This intuitive mobile app empowers participants to track and manage their antibiotic use seamlessly, providing valuable insights for the study. With antibiotic resistance posing a serious global health threat due to overuse and misuse, this research aims to inform safer, more effective antibiotic practices. Learn more.
🧑💻️ UPCOMING CONFERENCE
SCOPE 2025 is just around the corner this February! Our Chief Strategy Officer, Paul Donnelly, is geared up to share about AI enhancements of our award winning enterprise patient recruitment solution and the remote data collection platform with industry leaders from pharma, CROs, sites, advocacy groups, investors, and more. Don’t miss the chance to connect and discover how we’re revolutionizing clinical research. Schedule a meet with Paul here.
RECENT CURETALKS 
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Have Severe Alopecia Areata? If you are aged 18 years and older and have severe Alopecia Areata, you could contribute to this study investigating the effects of a medication given as a shot under the skin to treat this condition. Alopecia areata happens when the immune system attacks hair follicles, leading to hair loss.
Lend Your Ears (and Brains) For Hearing Research: Purdue University researchers aim to understand how our ears and brains help us perceive and communicate in complex environments, through this hearing research study. ANYONE who is 18 years of age or older, regardless of health condition, is invited to participate.
tACS Language: Researchers at Penn Medicine are investigating whether a form of noninvasive brain stimulation, called transcranial alternating current stimulation (tACS), will improve a person’s ability to name objects more than fake tACS. TACS is a technique by which small electric currents are applied to the scalp. This creates coordinated brain activity across the brain.
Electrical Stimulation for the Treatment of Optic Neuropathies: Researchers at Stanford University are investigating the safety and effectiveness of long-term electrical stimulation using a home-stimulation device for treating open-angle glaucoma. This study aims to understand whether electrical stimulation can slow optic nerve degeneration and improve outcomes for individuals with clinically stable glaucoma.
🌎 AROUND THE WEB
💡 From lab to life: AI bridges the gap in clinical trial applications.
🍳 AI intrigue: How DeepSeek is stirring up the tech world.
🧑⚕️ History of innovation: The first clinical trial wasn’t invented by a doctor?
🔭 Cosmic Sherlock: NASA’s super-scope plans to sniff out alien life.
‼️ NOTEWORTHY
🤝 TEAM UPDATES
YOGA AT NASA IWS HRP 2025🎉
Our CEO and Co-founder, Sharib Khan, isn’t just a tech visionary; he’s also a passionate yoga enthusiast and certified yoga guru. At NASA IWS HRP 2025, he led a rejuvenating 45-minute yoga session organized by the Translational Research Institute for Space Health, offering attendees the perfect mix of relaxation and energy before a day of inspiring talks. And our team did not forget to track Sharib’s live health stats as he guided the session!
YEAR-END HACKATHON🎉
This past December, we celebrated Hackathon 2024—our year-end tradition of innovation! Honoring TrialX’s roots in a hackathon 16 years ago, teams across the company came together for five days of creativity, collaboration, and breakthrough ideas—powered by passion and plenty of pizza + coffee. Learn more about what we built.
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
